WO1981002671A1
(en)
*
|
1980-03-20 |
1981-10-01 |
Ferring Farma Lab |
Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
|
US4960765A
(en)
*
|
1980-03-20 |
1990-10-02 |
Farmaceutisk Laboratorium Ferring A/S |
Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
|
EP0039306B1
(de)
*
|
1980-03-28 |
1984-01-11 |
Ciba-Geigy Ag |
Neue Azofarbstoffe, Verfahren zu deren Herstellung und deren Verwendung
|
SE8405924L
(sv)
*
|
1984-11-23 |
1986-05-24 |
Pharmacia Ab |
Nya azoforeningar
|
US4975233A
(en)
*
|
1988-12-09 |
1990-12-04 |
Hoechst Celanese Corporation |
Method of producing an enhanced polyester copolymer fiber
|
US5064637A
(en)
*
|
1989-05-30 |
1991-11-12 |
Board Of Regents, The University Of Texas System |
Substituted sulfonamide derivatives which inhibit allergic reactions
|
JPH0586844U
(ja)
*
|
1992-05-01 |
1993-11-22 |
株式会社柴崎製作所 |
ピルファープルーフキャップ
|
US5498608A
(en)
*
|
1994-01-07 |
1996-03-12 |
Salix Pharmaceuticals |
Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents
|
SE9700934D0
(sv)
|
1997-03-14 |
1997-03-14 |
Astra Ab |
New formulation
|
US6114382A
(en)
*
|
1998-11-11 |
2000-09-05 |
Moretti; Itagiba G. |
Methods for treating inflammatory bowel disease
|
JP4163946B2
(ja)
|
2000-08-29 |
2008-10-08 |
バイオコン・リミテッド |
免疫調節性化合物およびその誘導体並びにそれを用いて疾患を治療する方法
|
JP5112595B2
(ja)
*
|
2000-08-29 |
2013-01-09 |
バイオコン・リミテッド |
抗炎症活性および抗生物質活性を有する5−asa誘導体およびこれを用いて疾患を治療する方法
|
CA2359812C
(en)
*
|
2000-11-20 |
2004-02-10 |
The Procter & Gamble Company |
Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
|
US8048924B2
(en)
|
2001-08-29 |
2011-11-01 |
Biocon Limited |
Methods and compositions employing 4-aminophenylacetic acid compounds
|
PL2361620T3
(pl)
|
2004-02-06 |
2016-12-30 |
|
Zastosowanie aminosalicylanów w zespole jelita drażliwego z dominującą postacią biegunkową
|
EP1737469B1
(en)
*
|
2004-03-23 |
2018-08-15 |
Biocon Limited |
Methods and compositions employing 4-aminophenylacetic acid compounds
|
US20080306029A1
(en)
*
|
2004-05-28 |
2008-12-11 |
Salix Pharmaceuticals, Inc. |
Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
|
US7932366B2
(en)
*
|
2004-07-07 |
2011-04-26 |
Biocon Limited |
Synthesis of azo bonded immunoregulatory compounds
|
WO2006125293A1
(en)
*
|
2005-05-27 |
2006-11-30 |
Antibe Therapeutics Inc. |
Derivatives of 4- or 5-aminosalicylic acid
|
US7741359B2
(en)
*
|
2005-05-27 |
2010-06-22 |
Antibe Therapeutics Inc. |
Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs
|
US7498355B2
(en)
|
2005-05-27 |
2009-03-03 |
Antibe Therapeutics Inc. |
Derivatives of 4- or 5-aminosalicylic acid
|
US8921344B2
(en)
|
2006-11-03 |
2014-12-30 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
US7452872B2
(en)
|
2005-08-24 |
2008-11-18 |
Salix Pharmaceuticals, Inc. |
Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
|
CA2816276A1
(en)
*
|
2005-08-24 |
2007-03-01 |
Salix Pharmaceuticals, Inc. |
Balsalazide formulations and manufacture and use thereof
|
JP5421098B2
(ja)
*
|
2006-06-06 |
2014-02-19 |
ジーアイケア ファーマ インク. |
トリメブチン及びn−脱メチル化トリメブチンの塩類
|
US7271253B1
(en)
|
2006-08-10 |
2007-09-18 |
Apotex Pharmachem Inc. |
Safe process for the preparation of balsalazide
|
AU2008347024A1
(en)
|
2007-10-19 |
2009-07-16 |
Omm Scientific, Inc. |
Methods of inhibiting bacterial virulence and compounds relating thereto
|
US9303038B2
(en)
|
2011-09-06 |
2016-04-05 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of epilepsy and neurological diseases
|
CN102627624B
(zh)
*
|
2012-04-25 |
2014-03-19 |
西南大学 |
4-(4-氨基苯磺酰胺基)苯乙酸衍生物及其制备方法和应用
|
WO2013167985A1
(en)
|
2012-05-07 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of neurological disorders
|
US9399634B2
(en)
|
2012-05-07 |
2016-07-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of depression
|
US9642915B2
(en)
|
2012-05-07 |
2017-05-09 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neuromuscular disorders and neurodegenerative diseases
|
WO2013168025A1
(en)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for treatment of blood clotting disorders
|
WO2013167991A1
(en)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of metabolic disorders
|
US9403826B2
(en)
|
2012-05-08 |
2016-08-02 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of inflammatory disorders
|
WO2013167993A1
(en)
|
2012-05-08 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of neurological degenerative disorders
|
US9266823B2
(en)
|
2012-05-08 |
2016-02-23 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of parkinson's disease
|
US9315461B2
(en)
|
2012-05-10 |
2016-04-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurologic diseases
|
WO2013168011A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of chronic pain
|
US9394288B2
(en)
|
2012-05-10 |
2016-07-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of asthma and allergy
|
WO2013168033A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for treatment of neurologic diseases
|
US9499527B2
(en)
|
2012-05-10 |
2016-11-22 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of familial amyloid polyneuropathy
|
WO2013168012A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of respiratory disorders
|
WO2013168000A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of severe pain
|
US9233161B2
(en)
|
2012-05-10 |
2016-01-12 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological conditions
|
US9339484B2
(en)
|
2012-05-10 |
2016-05-17 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
|
WO2013168004A2
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of fibromyalgia pain
|
WO2013167997A2
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of metabolic syndrome
|
WO2013168001A1
(en)
|
2012-05-10 |
2013-11-14 |
Mahesh Kandula |
Compositions and methods for the treatment of moderate to severe pain
|
SG11201407318UA
(en)
|
2012-05-10 |
2014-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of metabolic syndrome
|
WO2013175376A2
(en)
|
2012-05-23 |
2013-11-28 |
Mahesh Kandula |
Compositions and methods for the treatment of local pain
|
US9227974B2
(en)
|
2012-05-23 |
2016-01-05 |
Cellex Bio Private Limited |
Compositions and methods for the treatment of respiratory disorders
|
JP2015518854A
(ja)
|
2012-05-23 |
2015-07-06 |
セリックスビオ プライヴェート リミテッド |
多発性硬化症の治療のための組成物および方法
|
WO2013175344A2
(en)
|
2012-05-23 |
2013-11-28 |
Mahesh Kandula |
Compositions and methods for the treatment of periodontitis and rheumatoid arthritis
|
CN104583182A
(zh)
|
2012-05-23 |
2015-04-29 |
塞利克斯比奥私人有限公司 |
用于治疗粘膜炎的组合物和方法
|
CN104603100A
(zh)
|
2012-05-23 |
2015-05-06 |
塞利克斯比奥私人有限公司 |
用于治疗炎症性肠病的组合物和方法
|
US9108942B1
(en)
|
2014-11-05 |
2015-08-18 |
Mahesh Kandula |
Compositions and methods for the treatment of moderate to severe pain
|
WO2014020480A2
(en)
|
2012-08-03 |
2014-02-06 |
Mahesh Kandula |
Compositions and methods for the treatment migraine and neurologic diseases
|
WO2014037833A2
(en)
|
2012-09-06 |
2014-03-13 |
Mahesh Kandula |
Compositions and methods for the treatment inflammation and lipid disorders
|
JP2015529218A
(ja)
|
2012-09-08 |
2015-10-05 |
セリックスビオ プライヴェート リミテッド |
炎症と脂質障害の治療のための組成物及び方法
|
US9333187B1
(en)
|
2013-05-15 |
2016-05-10 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of inflammatory bowel disease
|
EP3004049B1
(en)
|
2013-06-04 |
2018-09-05 |
Cellixbio Private Limited |
Compositions and methods for the treatment of diabetes and pre-diabetes
|
US9096537B1
(en)
|
2014-12-31 |
2015-08-04 |
Mahesh Kandula |
Compositions and methods for the treatment of mucositis
|
CN104974061B
(zh)
*
|
2014-04-14 |
2017-11-14 |
辽宁省药物研究院 |
一种巴柳氮钠的制备方法
|
NZ736131A
(en)
|
2014-09-26 |
2019-04-26 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of epilepsy and neurological disorders
|
CA2967908C
(en)
|
2014-09-29 |
2020-11-17 |
Mahesh Kandula |
Compositions and methods for the treatment of multiple sclerosis
|
CA2965449C
(en)
|
2014-10-27 |
2020-11-10 |
Cellix Bio Private Limited |
Three component salts of fumaric acid monomethyl ester with piperazine or ethylene diamine for the treatment of multiple sclerosis
|
US9284287B1
(en)
|
2014-11-05 |
2016-03-15 |
Cellix Bio Private Limited |
Compositions and methods for the suppression of carbonic anhydrase activity
|
US10208014B2
(en)
|
2014-11-05 |
2019-02-19 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological disorders
|
US9175008B1
(en)
|
2014-11-05 |
2015-11-03 |
Cellix Bio Private Limited |
Prodrugs of anti-platelet agents
|
US9150557B1
(en)
|
2014-11-05 |
2015-10-06 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of hyperglycemia
|
US9290486B1
(en)
|
2014-11-05 |
2016-03-22 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of epilepsy
|
US9321716B1
(en)
|
2014-11-05 |
2016-04-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of metabolic syndrome
|
US9173877B1
(en)
|
2014-11-05 |
2015-11-03 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of local pain
|
US9932294B2
(en)
|
2014-12-01 |
2018-04-03 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of multiple sclerosis
|
US9206111B1
(en)
|
2014-12-17 |
2015-12-08 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of neurological diseases
|
ES2905771T3
(es)
|
2015-01-06 |
2022-04-12 |
Cellix Bio Private Ltd |
Composiciones y procedimientos para el tratamiento de la inflamación y del dolor
|
CN110003044A
(zh)
*
|
2019-04-26 |
2019-07-12 |
赤峰蒙欣药业有限公司 |
一种巴柳氮钠的制备方法
|